title: An international comparison of case definition of severe adverse cutaneous reactions to medicines.
abstract: There is substantial intercountry variation in the proportion of cases of toxic epidermal necrolysis (TEN) and Stevens-Johnson syndrome (SJS) which are attributed to specific drugs. This study was undertaken to determine whether these differences might reflect biases in diagnosis of these conditions. A total of 138 reactions in 5 countries originally diagnosed as TEN or SJS were coded on to standardised forms. A single observer blind to the original diagnosis assessed each case according to specified criteria. This observer's diagnoses were compared with the original diagnoses. Overall, 111 of the 138 cases had information adequate for assessment. The blinded observer agreed with the diagnosis for 61% of cases where the original diagnosis was TEN and 58% of cases where the original diagnosis was SJS. There was no significant difference in rates of agreement when reactions attributed to sulphonamide antibiotics were compared with reactions attributed to other drugs. There were substantial and significant differences in percentage agreement between the blinded observer's diagnosis and the original diagnoses between countries. The lowest rates of agreement between the blinded observer and the original reports occurred in the US. Our results illustrate the difficulty in comparing reaction rates based on spontaneous reports between countries where the systems for gathering such reports vary. This illustrates the need for a minimum quantity of standard data and precise definitions of reactions if spontaneous reports of adverse reactions are to provide useful information about severe adverse skin reactions associated with drugs.
authors.affiliation: Department of Dermatology, Beth Israel Hospital, Harvard Medical School, Boston, Massachusetts.
authors.forename: R S
authors.initials: RS
authors.lastname: Stern
authors.forename: E
authors.initials: E
authors.lastname: Albengres
authors.forename: J
authors.initials: J
authors.lastname: Carlson
authors.forename: D
authors.initials: D
authors.lastname: Chen
authors.forename: C
authors.initials: C
authors.lastname: Kreft
authors.forename: W
authors.initials: W
authors.lastname: Dai
authors.forename: M
authors.initials: M
authors.lastname: Joseph
authors.forename: H
authors.initials: H
authors.lastname: Tilson
authors.forename: B E
authors.initials: BE
authors.lastname: Wiholm
authors.forename: C
authors.initials: C
authors.lastname: Kraft
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000009:adverse effects*; D004892:Erythema Multiforme / Q000139:chemically induced / Q000175:diagnosis; D005260:Female; D006801:Humans; D007391:International Cooperation; D008297:Male; D008875:Middle Aged; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced / Q000175:diagnosis* / Q000209:etiology; D013449:Sulfonamides / Q000009:adverse effects*
chemical_list: D000900:Anti-Bacterial Agents; D013449:Sulfonamides